Editas Medicine Names James C. Mullen as Chairman of the Board …GlobeNewswire (press release)CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the appointment o… Continue reading
News@NortheasternNovel synthetic biology technique could lead to breakthroughs in disease treatmentNews@NortheasternSynthetic biology offers a vision for the future of medicine, where cells could be re-engineered to fight diseases such as cancer and di… Continue reading
News@NortheasternNovel synthetic biology technique could lead to breakthroughs in disease treatmentNews@NortheasternSynthetic biology offers a vision for the future of medicine, where cells could be re-engineered to fight diseases such as cancer and di… Continue reading
Cambridge Network |
Building the business of biodesign
Cambridge Network Synthetic biology can be harnessed to address some of humanity’s most pressing challenges within a short five-year time period, according to a new report released today. The report summarises the findings of a workshop held earlier this year by … |
Technology Networks |
A New Gene Therapy for Brain Repair?
Technology Networks Reactive astrocytes surround the lesion site in the injured spinal cord. A new mouse study shows that triggering a gene inside astrocytes activates the star-shaped cells and may improve the brain’s ability to heal from a range of debilitating … |